144 related articles for article (PubMed ID: 25410176)
1. Applications of visual evoked potentials and Fourier-domain optical coherence tomography in Parkinson's disease: a controlled study.
Quagliato LB; Domingues C; Quagliato EM; Abreu EB; Kara-Junior N
Arq Bras Oftalmol; 2014 Aug; 77(4):238-42. PubMed ID: 25410176
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.
Garcia-Martin E; Rodriguez-Mena D; Satue M; Almarcegui C; Dolz I; Alarcia R; Seral M; Polo V; Larrosa JM; Pablo LE
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):696-705. PubMed ID: 24425856
[TBL] [Abstract][Full Text] [Related]
3. Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease.
Stemplewitz B; Keserü M; Bittersohl D; Buhmann C; Skevas C; Richard G; Hassenstein A
Acta Ophthalmol; 2015 Dec; 93(8):e672-7. PubMed ID: 26066643
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
[TBL] [Abstract][Full Text] [Related]
5. Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.
Bittersohl D; Stemplewitz B; Keserü M; Buhmann C; Richard G; Hassenstein A
Acta Ophthalmol; 2015 Nov; 93(7):e578-84. PubMed ID: 26267660
[TBL] [Abstract][Full Text] [Related]
6. Retinal thinning and correlation with functional disability in patients with Parkinson's disease.
Satue M; Seral M; Otin S; Alarcia R; Herrero R; Bambo MP; Fuertes MI; Pablo LE; Garcia-Martin E
Br J Ophthalmol; 2014 Mar; 98(3):350-5. PubMed ID: 24276697
[TBL] [Abstract][Full Text] [Related]
7. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.
Garcia-Martin E; Satue M; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Fernandez J; Pablo LE
Ophthalmology; 2012 Oct; 119(10):2161-7. PubMed ID: 22749083
[TBL] [Abstract][Full Text] [Related]
8. Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson's disease.
Unlu M; Gulmez Sevim D; Gultekin M; Karaca C
Neurol Sci; 2018 Mar; 39(3):533-541. PubMed ID: 29349656
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
Grecescu M
J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
[TBL] [Abstract][Full Text] [Related]
10. Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson's disease.
Hasanov S; Demirkilinc Biler E; Acarer A; Akkın C; Colakoglu Z; Uretmen O
Int Ophthalmol; 2019 Jun; 39(6):1255-1262. PubMed ID: 29744762
[TBL] [Abstract][Full Text] [Related]
11. Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.
Polo V; Satue M; Rodrigo MJ; Otin S; Alarcia R; Bambo MP; Fuertes MI; Larrosa JM; Pablo LE; Garcia-Martin E
BMJ Open; 2016 May; 6(5):e009658. PubMed ID: 27154474
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the visual system with visual evoked potential and optical coherence tomography in patients with idiopathic Parkinson's disease and with multiple system atrophy.
Batum M; Ak AK; Arı MS; Mayali H; Kurt E; Selçuki D
Doc Ophthalmol; 2022 Oct; 145(2):99-112. PubMed ID: 35881261
[TBL] [Abstract][Full Text] [Related]
13. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients.
Satue M; Garcia-Martin E; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Pablo LE; Fernandez FJ
Eye (Lond); 2013 Apr; 27(4):507-14. PubMed ID: 23429414
[TBL] [Abstract][Full Text] [Related]
14. Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration.
Sari ES; Koc R; Yazici A; Sahin G; Ermis SS
J Neuroophthalmol; 2015 Jun; 35(2):117-21. PubMed ID: 25485861
[TBL] [Abstract][Full Text] [Related]
15. Correlation Between Structural and Functional Retinal Changes in Parkinson Disease.
Kaur M; Saxena R; Singh D; Behari M; Sharma P; Menon V
J Neuroophthalmol; 2015 Sep; 35(3):254-8. PubMed ID: 25807477
[TBL] [Abstract][Full Text] [Related]
16. Photoreceptor layer thinning in idiopathic Parkinson's disease.
Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
[TBL] [Abstract][Full Text] [Related]
17. [A clinical study of changes in retina and visual field in patients with early Parkinson's disease].
Li L; Ji X; Mao C; Chen Y; Guo S; Li S; Liu C
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):521-4. PubMed ID: 26359014
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
Mailankody P; Battu R; Khanna A; Lenka A; Yadav R; Pal PK
Parkinsonism Relat Disord; 2015 Oct; 21(10):1164-9. PubMed ID: 26297381
[TBL] [Abstract][Full Text] [Related]
19. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
Miri S; Glazman S; Mylin L; Bodis-Wollner I
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S134-7. PubMed ID: 26414119
[TBL] [Abstract][Full Text] [Related]
20. The choroid and lamina cribrosa is affected in patients with Parkinson's disease: enhanced depth imaging optical coherence tomography study.
Eraslan M; Cerman E; Yildiz Balci S; Celiker H; Sahin O; Temel A; Suer D; Tuncer Elmaci N
Acta Ophthalmol; 2016 Feb; 94(1):e68-75. PubMed ID: 26268377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
